Christophe Mossé appointed as CEO of Arkopharma group
He will oversee Arkopharma’s activities and related activities of Dermapharm Group.
Brings industry expertise from leading groups: Naos, Galderma, Novartis,…
Founded in 1980 in Carros, near Nice, Arkopharma is a pharmaceutical laboratory specialized in phytotherapy, natural medicines, and dietary supplements.
Arkopharma, a European leader in its field, has announced the arrival of Christophe Mossé as CEO (cf. LinkedIn post below)
Christophe Mossé brings a wealth of experience in the pharmaceutical industry, both in France and internationally.
With his expertise, Christophe Mossé will lead Arkopharma’s activities and related operations of Dermapharm Group, and will be the main link between the management teams of the two entities.
Arkopharma is now present in more than 60 countries and is positioned as the European leader in phytotherapy medicines and dietary supplements.
With 1,212 employees and a consolidated turnover of 201 million euros, Arkopharma dedicates 8.5% of its workforce to research and development, with 1,635 registrations and marketing authorizations for medicines.
Health Nice Côte d’Azur
- Obesity: French first at Nice University Hospital
- Team Nice Côte d’Azur at the Van Lanschot Kempen Life Sciences Conference 2026
- Launch of the AZUR Territorial Research Entity to advance clinical research on the French Riviera
- BIO-Europe Spring 2026 : meet with Team Nice Côte d’Azur
- Eurobiomed: more than €300 million secured in 2025 in the Sud and Occitanie regions by Eurobiomed member healthcare companies
- Artificial intelligence: Team Nice Côte d’Azur mobilized for an AI Business Tour and WAICF 2026
- Nice University Hospital signs an international cooperation agreement with Emirates Hospitals Group (Dubai)
- Caranx Medical, a Nice-based cardiac robotics MedTech startup, set to be acquired for €16.6 million
- AVC continues its expansion with a consolidated base in the Côte d’Azur
- New medical governance at CHU de Nice
